Breast carcinoma is one of the greatest popular neoplasms in females. It is a major reason of demise in the world, and it is the first cancer in ranking diagnosed in Iraqi women. This study aimed to determine aminoacyltRAN-synthetase complex interacting multifunctional protein 1 and liver enzymes levels in Iraqi females with stage II breast malignance, and study the effect of chemotherapy (after surgery) on these markers. This study included 50 females patients with stage II breast malignance (before and after surgery and second dose of chemotherapy) attending the Oncology Teaching Hospital in Medical City/ Baghdad, in addition to 20 persons as controller group were chosen without any chronic diseases. Their ages ranged from (30-55) years. The results shown elevation inaminoacyltRAN-synthetase complex interacting multifunctional protein 1, CA15-3, liver function test levels, while there was a decrease in magnesium level in serum of females with stage II breast malignance before and after two dose chemotherapy when compared with the controls. The current revision is the first in follow-up of aminoacyltRAN-synthetasecomplex interacting multifunctional protein 1 level in serum of women patients with breast malignance before and after chemotherapy treatment. The aminoacyltRAN-synthetase complex interacting multifunctional protein 1may be a new bio-marker in breast malignance. Because the elevation in liver enzymes and decrease in magnesium levels, these patients may be more prone to liver damage, and the magnesium may be as a chemo-preventive agent from breast cancer because the inverse relationship between the magnesium and this disease.